Start by calling Cascade TMS at 503-344-3200
- First, there is an in-person intake with our TMS Coordinator to conduct a brief review of current and past treatments and to start the prior approval process if you plan using insurance coverage. Intake includes getting a release of information from all past mental health and medical providers and to provide an explanation of the TMS process.
- Next, you will interview with one of our attending physicians to review current and past treatment, and together we will review the previously collected records and medical history. It is at this point where determination of TMS treatment is either indicated or not.
- Finally, we will determine a TMS treatment schedule. This is done once you have completed the entire intake process and TMS treatment is indicated, then the treatments are scheduled. Treatments last 20 minutes and are typically scheduled 5 days per week for 4 weeks, then two final weeks of a tapering schedule conclude the treatment.
TMS is non-invasive and delivered in an office setting. It does not require anesthesia and patients are awake and alert during the treatment. The treatment is conducted while the patient sits in a comfortable chair and either watches television or listens to music.
Our TMS technician runs the prescribed treatments but you will have weekly checkups with the attending physician to assess progress. We offer follow-ups at 2 weeks and 6 weeks after completion of treatment, during which time, you will return to your current prescriber and therapist for ongoing care.
TMS should not be used for patients who have non-removable conductive metal in or near the head, including tattoo ink which contains metal.
The most common side effect is pain or discomfort at or near the treatment site (short lived headache). Some patients report headaches and scalp discomfort during TMS treatment, although this usually lessens over time and subsequent treatments. Although all medical treatments carry risks, the risks of TMS are considered to be very minimal, and is generally a very well tolerated treatment. There is a rare risk of seizure associated with TMS.